Trial intelligence / Profile preview

Antibiotic Prophylaxis in Congenital Kidney Abnormalities (PREDICT)

NCT02021006Phase 3Unknown

Sponsor
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Start
Dec 2013
Primary completion
Jan 2020
Modality
Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of nitrofurantoin, amoxicillin + clavulanate, cefixime, trimethoprim + sulfamethoxazole in urinary tract infection (UTI), sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Status: unknown.

02

Drugs

nitrofurantoinamoxicillin + clavulanatecefiximetrimethoprim + sulfamethoxazole
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on NCT02021006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02021006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call